Thymosin β4 coated nanofiber scaffolds for the repair of damaged cardiac tissue

25Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

After a cardiac event, proper treatment and care of the damaged tissue is crucial in restoring optimal cardiac function and preventing future cardiac events. Recently, thymosin β4 has been found to play a vital role in cardiac cell health and development by regulating angiogenesis, inflammatory responses, and wound healing. We proposed that defined poly(ε{lunate}-caprolactone) (PCL) nanoscaffolds coated with thymosin β4 could efficiently differentiate murine-derived cardiomyocytes into functioning cardiac tissue. PCL nanoscaffolds were developed through electrospinning technology, and subsequently coated with a thymosin β4 solution. Cardiomyocytes were seeded on coated and uncoated nanoscaffolds and observed for six days via fluorescent and electron microscopy. Our results demonstrated a robust growth and differentiation of cardiomyocytes on coated nanoscaffolds compared with uncoated, showing potential for nanoscaffold-mediated cardiac cell replacement in vivo after an MI or other cardiac event. © 2014 Kumar et al.; licensee BioMed Central Ltd.

Cite

CITATION STYLE

APA

Kumar, A., Patel, A., Duvalsaint, L., Desai, M., & Marks, E. D. (2014). Thymosin β4 coated nanofiber scaffolds for the repair of damaged cardiac tissue. Journal of Nanobiotechnology, 12(1). https://doi.org/10.1186/1477-3155-12-10

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free